Mendelsohn et al. [1] suggest Aotearoa/New Zealand's rapid smoking decline is because of less restrictive vaping policies, yet this claim is based on flawed assumptions and weaknesses in methods [2, 3]. The article selectively reports data to support pro‐vaping positions [4, 5, 6, 7], warranting caution from readers.
Extrapolating Aotearoa/New Zealand's smoking trend pre‐2019 to 2023 suggests only a 3% additional decline beyond the existing trajectory. Mendelsohn et al. [1] inflate vaping's role by downplaying pre‐existing smoking declines. They highlight Māori smoking reductions (35.5%–17.1%), but omit evidence of prior declines before widespread vape adoption [1].
Further, the study uses an unverified assumption to estimate Australia's 2016 smoking prevalence, inflating Aotearoa/New Zealand's comparative decline. The authors also fail to acknowledge vaping industry lobbying and the repeal of world‐leading tobacco policies [8, 9], instead framing vaping as indispensable to tobacco control.
Mendelsohn et al. [1] also commit a base rate fallacy [2], asserting: ‘The potential harm from additional vaping needs to be balanced against the likelihood that vaping is diverting some young people who would otherwise have smoked away from cigarettes.’ This ignores the steady decline in youth smoking before vapes entered the market and the simultaneous surge in nicotine uptake among youth who never smoked (Figures 1, 2, 3, 4) [10]. Rather than accelerating declines, vaping coincides with a flattening of smoking reductions.
FIGURE 1.

Regular smoking prevalence (1999–2024) and regular vaping (2015–2024) for year 10 students (14–15 years).
FIGURE 2.

Never smoking prevalence (1999–2024) and ever tried vaping (2015–2024) for year 10 students (14–15 years).
FIGURE 3.

Daily smoking prevalence by ethnicity (1999–2024) for year 10 students (14–15 years).
FIGURE 4.

Daily vaping prevalence by ethnicity (2015–2024) for year 10 students (14–15 years).
Mendelsohn et al. [1] imply Aotearoa/New Zealand's smoking decline is because of permissive vaping policies, despite briefly acknowledging this cannot be proven [1]. However, they fail to adequately consider alternative factors—tobacco control policies, enforcement, economic conditions and public health initiatives [1, 8, 11, 12]. This misrepresents correlation as causation [2, 3].
Mendelsohn et al. [1] use selective framing reinforces an industry viewpoint, neglecting alternative explanations [3]. The failure to adjust for pre‐existing smoking trends is a major methodological flaw [1, 3].
Mendelsohn et al. [1] selectively cite high smoking rates among Indigenous peoples to justify vaping policies without acknowledging the disproportionate harm of rising vaping rates [12, 13, 14, 15]. Among Māori youth, daily vaping rates now exceed historical smoking rates—contradicting claims that vaping is a cessation tool [9, 10]. This omission perpetuates a neo‐colonial approach that prioritises corporate interests over Indigenous sovereignty [1, 16, 17].
In summary, Mendelsohn et al. [1] misrepresent causation and downplay vaping‐related harms [9, 13]. Public health efforts should prioritise Indigenous‐led commercial tobacco resistance strategies, strengthen regulation and eliminate industry interference [18].
AUTHOR CONTRIBUTIONS
Raglan Maddox: Conceptualization (equal); data curation (equal); investigation (equal); methodology (equal); supervision (equal); validation (equal); writing—review and editing (equal). Andrew Waa: Conceptualization (equal); data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); project administration (equal); supervision (equal); validation (equal); writing—original draft (equal); writing—review and editing (equal). Tom Calma: Conceptualization (equal); formal analysis (equal); investigation (equal); methodology (equal); supervision (equal); writing—review and editing (equal). Lisa J Whop: Conceptualization (equal); formal analysis (equal); investigation (equal); methodology (equal); project administration (equal); supervision (equal); validation (equal); writing—review and editing (equal).
DECLARATION OF INTERESTS
None.
Funding information LJW is funded by a National Health and Medical Research Council Investigator Grant (#2009380).
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are publicly available.
REFERENCES
- 1. Mendelsohn CP, Beaglehole R, Borland R, Hall W, Wodak A, Youdan B, et al. Do the differing vaping and smoking trends in Australia and New Zealand reflect different regulatory policies? Addiction. 2025;120(7):1379–1389. 10.1111/add.70006 [DOI] [PubMed] [Google Scholar]
- 2. Rothman KJ, Huybrechts KF, Murray EJ. Epidemiology: an introduction Oxford university press; 2024. [Google Scholar]
- 3. European Centre for Disease Prevention and Control . Trend analysis guidance for surveillance data Stockholm: ECDC; 2024. [Google Scholar]
- 4. Legg T, Hatchard J, Gilmore AB. The science for profit model—how and why corporations influence science and the use of science in policy and practice. PLoS ONE. 2021;16(6):e0253272. 10.1371/journal.pone.0253272 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Pisinger C, Godtfredsen N, Bender AM. A conflict of interest is strongly associated with tobacco industry–favourable results, indicating no harm of e‐cigarettes. Prev Med. 2019;119:124–131. 10.1016/j.ypmed.2018.12.011 [DOI] [PubMed] [Google Scholar]
- 6. National Health and Medical Research Council . Identifying and managing conflicts of interest. 2018.
- 7. Rose SW, Tan AS, Bandi P, Maddox R, Berman M, Czaplicki L, et al. Commercial tobacco and nicotine industry‐funded research has no place in SRNT and Nicotine & Tobacco Research Oxford University Press US; 2024. p. 963–965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Andrew A. New Zealand's world‐first smokefree legislation'goes up in smoke': a setback in ending the tobacco epidemic. Health Policy. 2024;147:105123. 10.1016/j.healthpol.2024.105123 [DOI] [PubMed] [Google Scholar]
- 9. Hoek J, Ball J, Waa A, Graham‐DeMello A, Edwards R, Gregan M‐J. Mind the gap: associate health Minister's actions conflict with ministry advice, align with tobacco industry lobbying, 2024.
- 10. ASH New Zealand . ASH year 10 snapshot survey 2024 2024. Available from: https://assets.nationbuilder.com/ashnz/pages/170/attachments/original/1733961539/2024_ASH_Y10_Snapshot_Topline_smoking_and_vaping_Dec24_FINAL.pdf?1733961539
- 11. Ait Ouakrim D, Wilson T, Waa A, Maddox R, Andrabi H, Mishra SR, et al. Tobacco endgame intervention impacts on health gains and Māori:non‐Māori health inequity: a simulation study of the Aotearoa/New Zealand tobacco action plan. Tob Control. 2024;33(e2):e173–e184. 10.1136/tc-2022-057655 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Maddox R, Kennedy M, Drummond A, Waa A, Bradbrook S, Tautolo ES, et al. ‘Dispelling the smoke to reflect the mirror’: the time is now to eliminate tobacco related harms. Aust N Z J Public Health. 2022;46(6):727–729. 10.1111/1753-6405.13313 [DOI] [PubMed] [Google Scholar]
- 13. Banks E, Yazidjoglou A, Brown S, Nguyen M, Martin M, Beckwith K, et al. Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence. Med J Aust. 2023;218(6):267–275. 10.5694/mja2.51890 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Maddox R, Drummond A, Kennedy M, Martinez SA, Waa A, Henderson PN, et al. Ethical publishing in ‘indigenous’ contexts BMJ Publishing Group Ltd; 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Maddox R, Waa A, Lee K, Henderson PN, Blais G, Reading J, et al. Commercial tobacco and indigenous peoples: a stock take on framework convention on tobacco control progress. Tob Control. 2019;28(5):574–581. 10.1136/tobaccocontrol-2018-054508 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Harper A, Pratt B. Combatting neo‐colonialism in Health Research: what can aboriginal Health Research ethics and Global Health research ethics teach each other? J Empir Res Hum Res Ethics. 2022;17(4):431–454. 10.1177/15562646211058253 [DOI] [PubMed] [Google Scholar]
- 17. National Health and Medical Research Council . In: Commonwealth of Australia , editorEthical conduct in research with aboriginal and Torres Strait islander peoples and communities: guidelines for researchers and stakeholders (2018) Canberra, Australia; 2018. [Google Scholar]
- 18. Maddox R, Telford RM, Waa A, Diaz A, Bradbrook SK, Calma T, et al. Eradication of commercial tobacco related disease and death BMJ Publishing Group Ltd; 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are publicly available.
